PRTA

8.1702.74%
KL

Karin L. Walker

Chief Accounting Officer & Controller

Ms. Karin L. Walker, CPA, was Director of Cyclacel Pharmaceuticals, Inc. since November 9, 2020 until January 2025. She has been an Independent Director of LifeSci Acquisition Corp. since March 10, 2020. She has been the Chief Accounting Officer and Controller of Prothena Corporation plc since May 20, 2013. Ms. Walker served as the Vice President of Finance at Affymax, Inc. from October 2, 2012 to May 2013. Ms. Walker has joined Niku Corporation as Vice President of Finance. Prior to joining Niku, Ms. Walker held the positions of director of Finance and Corporate Controller at Financial Engines as well as NeoMagic Corp., where she helped take it public in 1997. From September 2009 to September 2012, Ms. Walker served as Vice President of Finance and Corporate Controller of Amyris Inc., a biotechnology company. From June 2006 to August 2009, Ms. Walker served as Vice President of Finance and Corporate Controller for CV Therapeutics, a biopharmaceutical company. Ms. Walker has extensive finance experience in biopharmaceuticals, including in public biotechnology companies and technology companies. Prior to joining Prothena, she was Chief Accounting Officer of Affymax, Inc., a position she held from 2012 to 2013. She also held finance positions at National Semiconductor, Conner Peripherals and Ernst and Young LLP. She held management positions at Knight Ridder Digital and Accellion. She is a certified public accountant. Ms. Walker is a CPA and she holds a B.S. in business and Finance from California State Polytechnic University, San Luis Obispo.

Positions